5.3.3.5	26,27-dehydrozymosterol	-	Homo sapiens	5beta-cholest-7-en-3beta-ol	-	?	368687	
5.3.3.5	26,27-dinorcholesta-8,24-dienol	-	Homo sapiens	26,27-dinorcholesta-7,24-dienol	-	?	368689	
5.3.3.5	26-homo-cholesta-8(9),23(24) E26(26')-trienol	-	Homo sapiens	26-homo-cholesta-7(8),23(24)E26(26')trienol	-	?	368688	
5.3.3.5	4alpha-methyl-5alpha-ergosta-8,24-dien-3beta-ol	-	Arabidopsis thaliana	24-methylenelophenol	i.e. 4alpha-methyl-5alpha-ergosta-7,24-dien-3beta-ol	?	418315	
5.3.3.5	4alpha-methyl-ergosta-8,24-dien-3beta-ol	-	Zea mays	?	-	?	399712	
5.3.3.5	4alpha-methyl-fecosterol	-	Zea mays	4alpha-methyl-ergosta-7,24-dien-3beta-ol	-	?	399713	
5.3.3.5	5alpha-Cholest-7-en-3beta-ol	-	Rattus norvegicus	5alpha-Cholest-8-en-3beta-ol	-	?	1102	
5.3.3.5	5alpha-Cholest-7-en-3beta-ol	r	Rattus norvegicus	5alpha-Cholest-8-en-3beta-ol	-	?	1102	
5.3.3.5	5alpha-cholest-7-en-3beta-ol	enzyme of the cholesterol biosynthetic pathway, mutations are associated with Conradi-Huenermann syndrome. The enzyme may be involved in liver function, since the mRNA is only detected in hepatocytes not in connective tissue or blood vessels. The expression of the SI gene is regulated transcriptionally in vitro and in vivo by widely known regulatory agents ranging from tamoxifen, an oestrogen receptor antagonist and SI-specific inhibitor, to cholesterol-lowering drugs	Rattus norvegicus	?	-	?	370718	
5.3.3.5	5alpha-cholesta-8,24-dien-3beta-ol	-	Homo sapiens	5alpha-cholesta-7,24-dien-3beta-ol	-	?	399747